Effect of Conjugated Linoleic Acid Supplement on Body Composition
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00347373 |
Recruitment Status
:
Completed
First Posted
: July 4, 2006
Last Update Posted
: July 4, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obesity | Drug: Tonalin Conjugated linoleic acid (dietary supplement) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | Conjugated Linoleic Acid and Body Fat Mass in Obese Humans |
Study Start Date : | August 2004 |
Study Completion Date : | September 2005 |

- Change in body fat mass at 12 weeks
- Change in lean body mass at 12 weeks
- Change in body mass index at 12 weeks
- Change in body weight at 12 weeks
- Change in energy expenditure at 12 weeks
- Change in lipid profile at 6 weeks and 12 weeks
- Change in clinical laboratory values at 6 weeks and 12 weeks (safety)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 50 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- BMI between 30 and 35 kg/m2
Exclusion Criteria:
- history of chronic disease
- food allergies or intolerances
- drug therapy for diagnosed disease or lipid-lowering
- use of weight-lowering medication or diet
- use of tobacco products
- current or planned pregnancy
- use of CLA supplement in previous 3 months
- current substance abuse
- abnormal clinical laboratory values

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00347373
United States, North Carolina | |
University of North Carolina at Chapel Hill | |
Chapel Hill, North Carolina, United States, 27599 |
Principal Investigator: | Susan E Steck, PhD, MPH, RD | University of North Carolina, Chapel Hill |
ClinicalTrials.gov Identifier: | NCT00347373 History of Changes |
Other Study ID Numbers: |
GCRC2166 |
First Posted: | July 4, 2006 Key Record Dates |
Last Update Posted: | July 4, 2006 |
Last Verified: | June 2006 |
Keywords provided by University of North Carolina, Chapel Hill:
conjugated linoleic acid obesity body composition body fat mass lean body mass |